The importance of listening to patients

A report yesterday on on the MedPage Today web site quotes Scott Gottlieb, MD, the Commissioner of the U.S. Food & Drug Administration (FDA) on the importance of “Listening to patients” and on how patients’ perspectives can inform drug development, drug review, and physicians’ prescribing habits. … READ MORE …

Some recent videos on the UroToday web site

One has to sign up to become a member of the UroToday web site, but there is no cost involved, and an attractive feature for prostate cancer patients is the regular, relatively brief, video-recorded interviews with experts on recent, specific issues. … READ MORE …

Is it or ain’t it “really” cancer?

In a new article in the Journal of Urology, researchers at Johns Hopkins Medical Center in Baltimore have again expressed their opinion that it would be inappropriate to rename low-risk Gleason 6 disease as something other than “cancer”. … READ MORE …

Report from APCCC 2017 on management of advanced prostate cancer

For those who really want all the details, the full text of the report from the Advanced Prostate Cancer Consensus Conference (APCCC) 2017 is now available on line. … READ MORE …

Men beware!

Editorial note: The following is an anonymous commentary that has been posted twice to this web site in recent days. Parts of it are factually accurate. Some of it is certainly factually inaccurate. Most of it appears to refer to the situation here in America. And a lot of it is personal opinion (as the author states). … READ MORE …

The value of second opinions, and who one gets them from

An interesting new paper published this morning in Cancer has shown that while lots of men have been getting second opinions from urologists on what to do about a diagnosis of prostate cancer, those second opinions don’t seem to have had much impact on their care. … READ MORE …

St. Gallen consensus conference on treatment of advanced prostate cancer

Apparently, early in 2015, there was a major international consensus conference, among nearly 50 of the leading international authorities, on the treatment of advanced prostate cancer. … READ MORE …